Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet
New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP
Dr Katherine Spira
Acute Migraine Management
A/Prof Gary Kilov AM
Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care
Dr Aviv Pudipeddi & Dr David Lim
Faecal Calprotectin – A Practical Guide to the Test and the New Item Number
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
